Abstract
The work reported in this paper investigates the use of a decision-support tool for the diagnosis of pigmented skin lesions in a real-world clinical trial with 511 patients and 3827 lesion evaluations. We analyzed a number of outcomes of the trial, such as direct comparison of system performance in laboratory and clinical setting, the performance of physicians using the system compared to a control dermatologist without the system, and repeatability of system recommendations. The results show that system performance was significantly less in the real-world setting compared to the laboratory setting (c-index of 0.87 vs. 0.94, p = 0.01). Dermatologists using the system achieved a combined sensitivity of 85% and combined specificity of 95%. We also show that the process of acquiring lesion images using digital dermoscopy devices needs to be standardized before sufficiently high repeatability of measurements can be assured.
Original language | English |
---|---|
Pages (from-to) | 191-195 |
Number of pages | 5 |
Journal | AMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA Symposium |
Publication status | Published - 2007 |
Keywords
- Decision Support Systems, Clinical
- Dermoscopy/methods
- Diagnosis, Computer-Assisted
- Humans
- Melanoma/diagnosis
- Sensitivity and Specificity
- Skin Neoplasms/diagnosis